G
Gillian L. Dalgliesh
Researcher at Wellcome Trust Sanger Institute
Publications - 15
Citations - 6863
Gillian L. Dalgliesh is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Mutation & Cancer. The author has an hindex of 10, co-authored 15 publications receiving 6428 citations. Previous affiliations of Gillian L. Dalgliesh include University of Oklahoma Health Sciences Center & University of Glasgow.
Papers
More filters
Journal ArticleDOI
Patterns of somatic mutation in human cancer genomes
Christopher Greenman,Philip J. Stephens,Raffaella Smith,Gillian L. Dalgliesh,Christopher I. Hunter,Graham R. Bignell,Helen Davies,Jon W. Teague,Adam Butler,Claire Stevens,Sarah Edkins,Sarah O’Meara,Imre Vastrik,Esther Schmidt,Tim Avis,Syd Barthorpe,Gurpreet Bhamra,Gemma Buck,Bhudipa Choudhury,Jody Clements,Jennifer Cole,Ed Dicks,Simon A. Forbes,Kris Gray,Kelly Halliday,Rachel Harrison,Katy Hills,Jon Hinton,Andy Jenkinson,David T. Jones,Andy Menzies,Tatiana Mironenko,Janet Perry,Keiran Raine,Dave Richardson,Rebecca Shepherd,Alexandra Small,Calli Tofts,Jennifer Varian,Tony Webb,Sofie West,Sara Widaa,Andrew D. Yates,Daniel P. Cahill,David N. Louis,Peter Goldstraw,Andrew G. Nicholson,Francis Brasseur,Leendert H. J. Looijenga,Barbara L. Weber,Yoke Eng Chiew,Anna deFazio,Mel Greaves,Anthony R. Green,Peter J. Campbell,Ewan Birney,Douglas F. Easton,Georgia Chenevix-Trench,Min-Han Tan,Sok Kean Khoo,Bin Tean Teh,Siu Tsan Yuen,Suet Yi Leung,Richard Wooster,P. Andrew Futreal,Michael R. Stratton,Michael R. Stratton +66 more
TL;DR: More than 1,000 somatic mutations found in 274 megabases of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers reveal the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.
Journal ArticleDOI
Exome sequencing identifies frequent mutation of the SWI/SNF Complex Gene PBRM1 in renal carcinoma
Ignacio Varela,Patrick S. Tarpey,Keiran Raine,Dachuan Huang,Choon Kiat Ong,Philip J. Stephens,Helen Davies,David T. Jones,Meng-Lay Lin,Jon W. Teague,Graham R. Bignell,Adam Butler,Juok Cho,Gillian L. Dalgliesh,Danushka Galappaththige,Christopher Greenman,Claire Hardy,Mingming Jia,Calli Latimer,King Wai Lau,John Marshall,Stuart McLaren,Andrew Menzies,Laura Mudie,Lucy Stebbings,David A. Largaespada,Lodewyk F. A. Wessels,Stéphane Richard,Stéphane Richard,Richard J. Kahnoski,John Anema,David A. Tuveson,Pedro A. Perez-Mancera,Ville Mustonen,Andrej Fischer,Andrej Fischer,David J. Adams,Alistair G. Rust,Waraporn Chan-on,Chutima Subimerb,Karl Dykema,Kyle A. Furge,Peter J. Campbell,Bin Tean Teh,Bin Tean Teh,Michael R. Stratton,P. Andrew Futreal +46 more
TL;DR: The protein coding exome is sequenced in a series of primary ccRCC and the identification of the SWI/SNF chromatin remodelling complex gene PBRM1 is reported as a second majorccRCC cancer gene, with truncating mutations in 41% (92/227) of cases.
Journal ArticleDOI
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh,Kyle A. Furge,Christopher Greenman,Lina Chen,Graham R. Bignell,Adam Butler,Helen Davies,Sarah Edkins,Claire Hardy,Calli Latimer,Jon W. Teague,Jenny Andrews,Syd Barthorpe,Dave Beare,Gemma Buck,Peter J. Campbell,Simon A. Forbes,Mingming Jia,David T. Jones,Henry Knott,Chai Yin Kok,King Wai Lau,Catherine Leroy,Meng-Lay Lin,David J. McBride,Mark Maddison,Simon Maguire,Kirsten McLay,Andrew Menzies,Tatiana Mironenko,Lee Mulderrig,Laura Mudie,Sarah O’Meara,Erin Pleasance,Aarjunan Rajasingham,Rebecca Shepherd,Raffaella Smith,Lucy Stebbings,Philip J. Stephens,Gurpreet Tang,Patrick S. Tarpey,Kelly Turrell,Karl Dykema,Sok Kean Khoo,David Petillo,Bill Wondergem,John Anema,Richard J. Kahnoski,Bin Tean Teh,Bin Tean Teh,Michael R. Stratton,Michael R. Stratton,P. Andrew Futreal +52 more
TL;DR: The identification of inactivating mutations in two genes encoding enzymes involved in histone modification and NF2 mutations were found in non-VHL mutated ccRCC, and several other probable cancer genes were identified, indicating that substantial genetic heterogeneity exists in a cancer type dominated by mutations in a single gene.
Journal ArticleDOI
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften,Gillian L. Dalgliesh,Helen Davies,Lina Chen,Graham R. Bignell,Christopher Greenman,Sarah Edkins,Claire Hardy,Sarah O’Meara,Jon W. Teague,Adam Butler,Jonathan Hinton,Calli Latimer,Jenny Andrews,Syd Barthorpe,Dave Beare,Gemma Buck,Peter J. Campbell,Jennifer Cole,Simon A. Forbes,Mingming Jia,David T. Jones,Chai Yin Kok,Catherine Leroy,Meng-Lay Lin,David J. McBride,Mark Maddison,Simon Maquire,Kirsten McLay,Andrew Menzies,Tatiana Mironenko,Lee Mulderrig,Laura Mudie,Erin Pleasance,Rebecca Shepherd,Raffaella Smith,Lucy Stebbings,Philip J. Stephens,Gurpreet Tang,Patrick S. Tarpey,Rachel Turner,Kelly Turrell,Jennifer Varian,Sofie West,Sara Widaa,Paul Wray,V. Peter Collins,Koichi Ichimura,Simon Law,John Wong,Siu Tsan Yuen,Suet Yi Leung,Giovanni Tonon,Giovanni Tonon,Ronald A. DePinho,Yu-Tzu Tai,Kenneth C. Anderson,Richard J. Kahnoski,Aaron Massie,Sok Kean Khoo,Bin Tean Teh,Michael R. Stratton,Michael R. Stratton,P. Andrew Futreal +63 more
TL;DR: UTX reintroduction into cancer cells with inactivating UTX mutations resulted in slowing of proliferation and marked transcriptional changes, identifying UTX as a new human cancer gene.
Journal ArticleDOI
Signatures of mutation and selection in the cancer genome
Graham R. Bignell,Christopher Greenman,Helen Davies,Adam Butler,Sarah Edkins,Jenny Andrews,Gemma Buck,Lina Chen,David Beare,Calli Latimer,Sara Widaa,Jonathon Hinton,Ciara Fahey,Beiyuan Fu,Sajani Swamy,Gillian L. Dalgliesh,Bin Tean Teh,Panos Deloukas,Fengtang Yang,Peter J. Campbell,P. Andrew Futreal,Michael R. Stratton,Michael R. Stratton +22 more
TL;DR: Structural signatures are derived that distinguish between homozygous deletions over recessive cancer genes and fragile sites and illustrate how structural signatures can be used to distinguish between the influences of mutation and selection in cancer genomes.